WSJ Tech Council Summit: CVS Exec Has 'Serious Allergy' to Chief AI Officer Trend
Dow Jones
1 hour ago
0956 ET - Tilak Mandadi, chief experience and technology officer at CVS Health, says he has a "serious allergy" to the growing trend of companies appointing chief AI officers. "The problem with associating a person with a technology is that that technology suddenly becomes the solution for everything, because their bonus depends on the adoption of that technology," he says at the WSJ Technology Council Summit. Mandadi says companies should have C-suite roles that prioritize outcomes, instead. That would allow executives to consider a range of tools and strategies, before deciding on which can best achieve the desired effect, he says.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.